Stock Events

Stock Events

Cytosorbents 

€0.2960
0
-€0.00-0.67% Friday 19:56

Statistics

Day High
5.92
Day Low
0.27
52W High
5.92
52W Low
0.27
Volume
0
Avg. Volume
187
Mkt Cap
930,072.55
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q1 2026
Q2 2026
Next
-0.87
-0.59
-0.32
-0.04
Expected EPS
-0.77328
Actual EPS
N/A

Financials

-22.07%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
32.18MRevenue
-7.1MNet Income

Analyst Ratings

7.59Average Price Target
The highest estimate is 7.59.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HQE1.STU. It's not an investment recommendation.
Rigetti Computing
6
RGTI
Teucrium Wheat Fund
5
WEAT
Realty Income
4
O
NVIDIA
4
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap13.35B
Baxter International offers a range of dialysis products and acute therapies, directly competing with Cytosorbents' blood purification solutions.
Medtronic
MDT
Mkt Cap120.46B
Medtronic offers products for dialysis and blood management, competing in the broader market of medical devices for critical care, similar to Cytosorbents.
Danaher
DHR
Mkt Cap145.98B
Danaher Corporation, through its subsidiary Cytiva, provides products and services for life sciences research, competing in the bioprocessing space with Cytosorbents.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation competes in the medical devices sector, offering products that could be used in similar clinical settings as Cytosorbents' therapies.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation manufactures medical devices and equipment, including products for intensive care, which could be seen as complementary or competitive to Cytosorbents' offerings.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products, competing in the broader healthcare and medical device market.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its medical devices segment, competes across various healthcare sectors, including areas relevant to Cytosorbents' market.
Edwards Lifesciences
EW
Mkt Cap51.82B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the critical care space where Cytosorbents operates.
SeaStar Medical
ICU
Mkt Cap13.13M
ICU Medical provides infusion therapy and critical care products, competing in the market for medical devices and technologies for critical patient care.

About

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Show more...
CEO
Phillip Chan
Employees
129
Country
United States
ISIN
US23283X2062
WKN
000A12GDU

Listings

STU
DE
HQE1.STU
BOATS
BOATS
CTSO.BOATS
MU
DE
HQE1.MU
F
DE
HQE1.F

0 Comments

Share your thoughts

FAQ

What is Cytosorbents stock price today?▼
The current price of HQE1.STU is €0.30 EUR — it has decreased by -0.67% in the past 24 hours. Watch Cytosorbents stock price performance more closely on the chart.
What is Cytosorbents stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Cytosorbents stocks are traded under the ticker HQE1.STU.
Is Cytosorbents stock price growing?▼
HQE1.STU stock has fallen by -0.67% compared to the previous week, the month change is a -3.9% fall, over the last year Cytosorbents has showed a -63.64% decrease.
What is Cytosorbents market cap?▼
Today Cytosorbents has the market capitalization of 930,072.55
When is the next Cytosorbents earnings date?▼
Cytosorbents is going to release the next earnings report on October 29, 2026.
What were Cytosorbents earnings last quarter?▼
HQE1.STU earnings for the last quarter are -0.87 EUR per share, whereas the estimation was -0.78 EUR resulting in a -11.11% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Cytosorbents revenue for the last year?▼
Cytosorbents revenue for the last year amounts to 32.18M EUR.
What is Cytosorbents net income for the last year?▼
HQE1.STU net income for the last year is -7.1M EUR.
How many employees does Cytosorbents have?▼
As of September 10, 2026, the company has 129 employees.
In which sector is Cytosorbents located?▼
Cytosorbents operates in the Health & Wellness sector.
When did Cytosorbents complete a stock split?▼
The last stock split for Cytosorbents was on December 05, 2014 with a ratio of 1:25.
Where is Cytosorbents headquartered?▼
Cytosorbents is headquartered in PRINCETON, United States.